886503-02-2 Usage
Uses
Used in Medicinal Chemistry:
2-(2-Trifluoromethoxy-phenyl)-pyrrolidine is utilized as a building block in the synthesis of pharmaceutical compounds. Its unique properties and structural flexibility make it a key component in the development of new drugs.
Used in Drug Discovery:
In the field of drug discovery, 2-(2-Trifluoromethoxy-phenyl)-pyrrolidine serves as an important intermediate for the production of biologically active molecules. Its potential for contributing to the creation of effective therapeutic agents is significant, given its capacity to enhance the properties of synthesized compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 886503-02-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,6,5,0 and 3 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 886503-02:
(8*8)+(7*8)+(6*6)+(5*5)+(4*0)+(3*3)+(2*0)+(1*2)=192
192 % 10 = 2
So 886503-02-2 is a valid CAS Registry Number.
886503-02-2Relevant articles and documents
A class of histone acetylase p300 inhibitors, and application thereof
-
Paragraph 0191-0192; 0199-0201, (2020/06/17)
The invention discloses a class of histone acetylase p300 inhibitors, and application thereof, and belongs to the technical field of medicinal chemistry. The invention discloses a compound representedby a formula (I), or a stereochemical isomer, a solvate or a pharmaceutically acceptable salt thereof. According to the invention, the compound can effectively inhibit the activity of histone acetylase p300 and can effectively inhibit the proliferation activity of various tumor cells; the compound is combined with a CDK4/6 inhibitor to play a synergistic role in inhibiting proliferation of tumorcells; and the compound has good application prospects in preparation of histone acetylase inhibitors, preparation of drugs for preventing and/or treating cancers, metabolic diseases, neurological diseases or inflammations, and combination of drugs.
